How it started?
The Kos Foundation embodies the vision and commitment of an individual dedicated to creating a meaningful and lasting impact on the lives of others.
HISTORY
The Kos Foundation was established in recognition of a dedicated group of community members, including Zdenko Kos, who initiated pioneering research into cancer treatments in 2011. This approach was founded on the principle that each person’s DNA is unique and that, accordingly, medicines should be tailored to individuals or groups of patients with similar genetic profiles, rather than developed and administered through a generic model of cancer treatment.
The Kos Foundation remains committed to sharing and advancing this important work.
Our Involvement in Numbers
30
COUNTRIES WHERE WE ARE INVOLVED
Austria, Belarus, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and United Kingdom
472 + 192
OUR REGULAR "MAGIC CIRCLE" TEAM
Our 24/7/365 team comprises 472 scientists, doctors, consultants, surgeons, anaesthetists, laboratory specialists, specialist medical professionals, private researchers, pharma-cists and freelancers who work closely with hospitals across Europe and the United Kingdom. They are supported daily by 192 M&M staff members, including 64 project and logistics centre managers, 44 transport workers and 20 pharmacists.
88
CURRENTLY PROGRAMMS IN NUMBERS
Tested & Treated in period 2020 till 2025 with new medication in the United Kingdom, Switzerland, Germany and Italy:
Brain Cancer: 210,252 Patients
Breast Cancer: 420,826 Patients
Colon/Rectum Cancer: 406,807 Patients
Lung/Bronchus Cancer: 580,624 Patients
Prostate Cancer: 349,662 Patients
Skin Cancer: 214,338 Patients